|
SEPT10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.48670000146944E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.49520000112003E-08 |
| Normal-vs-Stage2 |
1.041450E-04 |
| Normal-vs-Stage3 |
9.178700E-03 |
| Normal-vs-Stage4 |
1.103570E-02 |
| Stage1-vs-Stage2 |
9.461200E-01 |
| Stage1-vs-Stage3 |
4.557000E-01 |
| Stage1-vs-Stage4 |
1.905410E-01 |
| Stage2-vs-Stage3 |
6.032600E-01 |
| Stage2-vs-Stage4 |
3.540000E-01 |
| Stage3-vs-Stage4 |
7.087800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37669994795908E-09 |
| Normal-vs-AfricanAmerican |
4.540700E-03 |
| Normal-vs-Asian |
5.497800E-03 |
| Caucasian-vs-AfricanAmerican |
1.038810E-01 |
| Caucasian-vs-Asian |
9.080200E-01 |
| AfricanAmerican-vs-Asian |
6.477800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.39860020734284E-10 |
| Normal-vs-Female |
6.787800E-02 |
| Male-vs-Female |
1.017880E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.578800E-04 |
| Normal-vs-Extreme_Weight |
9.14990305744823E-11 |
| Normal-vs-Obese |
5.792700E-04 |
| Normal-vs-Extreme_Obese |
2.955600E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.772600E-01 |
| Normal_Weight-vs-Obese |
3.870200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.698000E-01 |
| Extreme_Weight-vs-Obese |
2.076200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.070800E-01 |
| Obese-vs-Extreme_Obese |
3.700400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.485800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.87935000000028E-05 |
| Normal-vs-Age(61-80Yrs) |
1.33730004847621E-09 |
| Normal-vs-Age(81-100Yrs) |
2.75090000001477E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.370200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.504320E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.111750E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.830400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.028300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.923200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.91840002059263E-09 |
| Normal-VS-Type2 PRCC |
2.165399999976E-06 |
| Normal-VS-KIRP CIMP |
4.248000E-01 |
| Normal-VS-Unclassified PRCC |
4.780700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.357600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.771100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.745400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.162000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.770000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.216400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.75639999608646E-08 |
| Normal-vs-N1 |
5.234100E-02 |
| Normal-vs-N2 |
3.080300E-03 |
| N0-vs-N1 |
5.728000E-02 |
| N0-vs-N2 |
8.873800E-01 |
| N1-vs-N2 |
3.715600E-01 |
|
|
